AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Health Equity
Health inequities persist in the U.S. and globally, especially in low- and middle-income countries, where limited access to care leads to poorer outcomes. This section explores cancer through the lens of equity, highlighting emerging research, tools, and technologies working to close the gap and advance more just, inclusive cancer care.
The Silent Ecosystem Within Clinical Trials
By Zoë Swainson, MHA
Clinical trial outcomes do not emerge solely by science. They also emerge from an invisible ecosystem of trust, coordination, compassion and operational excellence.
The Silent Ecosystem Within Clinical Trials
By Zoë Swainson, MHA
Clinical trial outcomes do not emerge solely by science. They also emerge from an invisible ecosystem of trust, coordination, compassion and operational excellence.
The Silent Ecosystem Within Clinical Trials
By Zoë Swainson, MHA
Clinical trial outcomes do not emerge solely by science. They also emerge from an invisible ecosystem of trust, coordination, compassion and operational excellence.
Overcoming Language Barriers in Cancer Care
By Kaila Johnson
Language barriers delay cancer diagnoses and lower screening rates for patients with limited English proficiency. Experts weigh in on interpreter access, cultural competence, and why closing these gaps is critical to equitable cancer care.
Overcoming Language Barriers in Cancer Care
By Kaila Johnson
Language barriers delay cancer diagnoses and lower screening rates for patients with limited English proficiency. Experts weigh in on interpreter access, cultural competence, and why closing these gaps is critical to equitable cancer care.
Overcoming Language Barriers in Cancer Care
By Kaila Johnson
Language barriers delay cancer diagnoses and lower screening rates for patients with limited English proficiency. Experts weigh in on interpreter access, cultural competence, and why closing these gaps is critical to equitable cancer care.
Rural Cancer Care and the Dollar Sign on Your Diagnosis
By Ariana Sutherland, MSc
A stage 4 breast cancer patient in Juneau had no local oncologist and spent thousands flying to Seattle for care. Her story puts a human face on rural cancer care's structural failures — and what it would take to fix them.
Rural Cancer Care and the Dollar Sign on Your Diagnosis
By Ariana Sutherland, MSc
A stage 4 breast cancer patient in Juneau had no local oncologist and spent thousands flying to Seattle for care. Her story puts a human face on rural cancer care's structural failures — and what it would take to fix them.
Rural Cancer Care and the Dollar Sign on Your Diagnosis
By Ariana Sutherland, MSc
A stage 4 breast cancer patient in Juneau had no local oncologist and spent thousands flying to Seattle for care. Her story puts a human face on rural cancer care's structural failures — and what it would take to fix them.
CAR-T's Real Toxicity Is Delay
By Carolina Escobar, MD
CAR-T physician training centers on managing key toxicities: CRS (fever, hypotension, organ dysfunction) and ICANS (confusion, tremors, seizures).
CAR-T's Real Toxicity Is Delay
By Carolina Escobar, MD
CAR-T physician training centers on managing key toxicities: CRS (fever, hypotension, organ dysfunction) and ICANS (confusion, tremors, seizures).
CAR-T's Real Toxicity Is Delay
By Carolina Escobar, MD
CAR-T physician training centers on managing key toxicities: CRS (fever, hypotension, organ dysfunction) and ICANS (confusion, tremors, seizures).
Why a Child's Zip Code May Be Their Most Important Cancer Prognostic Factor
By The Cancer News Team
To illustrate what a 20% survival rate looks like in practice, Force opens with a case: a 10-year-old boy brought to a rural East African hospital by his grandmother with a progressive jaw mass, intermittent fevers, and microcytic anemia.
Why a Child's Zip Code May Be Their Most Important Cancer Prognostic Factor
By The Cancer News Team
To illustrate what a 20% survival rate looks like in practice, Force opens with a case: a 10-year-old boy brought to a rural East African hospital by his grandmother with a progressive jaw mass, intermittent fevers, and microcytic anemia.
Why a Child's Zip Code May Be Their Most Important Cancer Prognostic Factor
By The Cancer News Team
To illustrate what a 20% survival rate looks like in practice, Force opens with a case: a 10-year-old boy brought to a rural East African hospital by his grandmother with a progressive jaw mass, intermittent fevers, and microcytic anemia.
"I Think of Myself as a Plumber": The Engineer Trying to Fix Global Diagnostic Inequity
By Ariana Sutherland, MSc
"I think of myself as a plumber by training," Ayokunle Olanrewaju, PhD, says to a room of oncology healthcare providers.
"I Think of Myself as a Plumber": The Engineer Trying to Fix Global Diagnostic Inequity
By Ariana Sutherland, MSc
"I think of myself as a plumber by training," Ayokunle Olanrewaju, PhD, says to a room of oncology healthcare providers.
"I Think of Myself as a Plumber": The Engineer Trying to Fix Global Diagnostic Inequity
By Ariana Sutherland, MSc
"I think of myself as a plumber by training," Ayokunle Olanrewaju, PhD, says to a room of oncology healthcare providers.
Asking Because We Care: Why SOGI Data Is Essential to Equitable Cancer Care
By Tiffany Go, MPA, CPCHE
LGBTQ+ patients face real cancer care disparities—and without SOGI data, they remain invisible. A health equity leader at Fred Hutch makes the case for standardized, affirming data collection across cancer care settings.
Asking Because We Care: Why SOGI Data Is Essential to Equitable Cancer Care
By Tiffany Go, MPA, CPCHE
LGBTQ+ patients face real cancer care disparities—and without SOGI data, they remain invisible. A health equity leader at Fred Hutch makes the case for standardized, affirming data collection across cancer care settings.
Asking Because We Care: Why SOGI Data Is Essential to Equitable Cancer Care
By Tiffany Go, MPA, CPCHE
LGBTQ+ patients face real cancer care disparities—and without SOGI data, they remain invisible. A health equity leader at Fred Hutch makes the case for standardized, affirming data collection across cancer care settings.
Curing the Cancer Does Not Fix the Patient: The Case for Healthcare Transition in Pediatric Oncology
By Mortuma Murry, DNP, CPNP-AC/PC
Why curing cancer isn’t enough—exploring the urgent need for structured healthcare transition programs to support pediatric cancer patients into adulthood and survivorship.
Curing the Cancer Does Not Fix the Patient: The Case for Healthcare Transition in Pediatric Oncology
By Mortuma Murry, DNP, CPNP-AC/PC
Why curing cancer isn’t enough—exploring the urgent need for structured healthcare transition programs to support pediatric cancer patients into adulthood and survivorship.
Curing the Cancer Does Not Fix the Patient: The Case for Healthcare Transition in Pediatric Oncology
By Mortuma Murry, DNP, CPNP-AC/PC
Why curing cancer isn’t enough—exploring the urgent need for structured healthcare transition programs to support pediatric cancer patients into adulthood and survivorship.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Kaposi Sarcoma in 2026: A Disease Controlled in the West, Still Devastating sub-Saharan Africa
By David Aboulafia, MD
Kaposi sarcoma highlights stark global inequities, with effective control in high-income countries but devastating impact in sub-Saharan Africa due to limited ART access, infrastructure gaps, and delayed diagnosis.
Real-World Impact: Applying SABCS 2025 Advances in Community Oncology
By Sara Zhukovsky, MD; Christos Vaklavas, MD
How SABCS 2025 advances are transforming community oncology, with practical strategies to improve breast cancer screening, treatment adherence, survivorship care, and equitable access.
Real-World Impact: Applying SABCS 2025 Advances in Community Oncology
By Sara Zhukovsky, MD; Christos Vaklavas, MD
How SABCS 2025 advances are transforming community oncology, with practical strategies to improve breast cancer screening, treatment adherence, survivorship care, and equitable access.
Real-World Impact: Applying SABCS 2025 Advances in Community Oncology
By Sara Zhukovsky, MD; Christos Vaklavas, MD
How SABCS 2025 advances are transforming community oncology, with practical strategies to improve breast cancer screening, treatment adherence, survivorship care, and equitable access.